Evidence map›Paper›PMID 33226334›Full record

ArticleJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2021

Daily associations between sleep and opioid use among adults with comorbid symptoms of insomnia and fibromyalgia.

Mary Beth Miller, Ashley F Curtis, Wai Sze Chan, Chelsea B Deroche, Christina S McCrae

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Mary Beth MillerDepartment of Psychiatry, University of Missouri School of Medicine, Columbia, Missouri.
Ashley F CurtisDepartment of Psychiatry, University of Missouri School of Medicine, Columbia, Missouri.
Wai Sze ChanDepartment of Psychology, The University of Hong Kong, Hong Kong.
Chelsea B DerocheDepartment of Psychiatry, University of Missouri School of Medicine, Columbia, Missouri.
Christina S McCraeDepartment of Psychiatry, University of Missouri School of Medicine, Columbia, Missouri.
University of Missouri · USUniversity of Hong Kong · HK

Funding

Sleep and Pain Interventions in Fibromyalgia: Hyperalgesia and Central SensitizatR01AR055160 · NIAMS · UNIVERSITY OF FLORIDA · PI MCCRAE, CHRISTINA S · 2008 to 2012
$1.9M
The Impact of Insomnia Treatment on Heavy Alcohol Use among Returning VeteransK23AA026895 · NIAAA · UNIVERSITY OF MISSOURI-COLUMBIA · PI MILLER, MARY ELIZABETH · 2019 to 2023
$896k
The Impact of CBT for Insomnia on Alcohol Treatment Outcomes among VeteransR21AA025715 · NIAAA · UNIVERSITY OF MISSOURI-COLUMBIA · PI MCGEARY, JOHN E, METRIK, JANE · 2018 to 2019
$417k
NIAAA NIH HHS K23 AA026895NIAAA NIH HHS L30 AA025226NIAMS NIH HHS R01 AR055160
6 · The paper itself

Abstract

STUDY

objectivesDisturbed sleep and use of opioid pain medication are common among individuals with chronic pain. Anecdotally, opioids are thought to promote sleep by relieving pain. This study aimed to determine whether opioid use is associated with daily sleep parameters (and vice versa) in adults with comorbid symptoms of insomnia and fibromyalgia.

methodsIndividuals reporting symptoms of insomnia and opioid use for fibromyalgia (n = 65, 93% women, 79% White) wore wrist actigraphy and completed daily diaries for 14 days (910 observations). Analyses examined daily associations between opioid dose (measured in lowest recommended dosage units) and three sleep parameters (actigraphy/self-reported total wake time and self-reported sleep quality). Multilevel models were used to account for the clustering of daily sleep and opioid assessments (level 1) within individuals (level 2).

resultsOpioid use did not have a significant daily effect on total wake time or sleep quality, and sleep parameters did not significantly impact opioid use the next day; however, participants reported worse sleep quality and greater doses of opioids on evenings that they experienced greater pain.

conclusionsAmong adults reporting symptoms of insomnia and opioid use for fibromyalgia pain, opioid use is not reliably associated with wake time or sleep quality that night, and these sleep parameters are not significantly associated with opioid use the next day; however, evening pain has an adverse daily impact on both sleep quality and opioid use. Studies identifying strategies to prevent and manage fibromyalgia pain are needed, especially for individuals reporting comorbid insomnia and opioid use.

Indexed as

FibromyalgiaOpioid-Related DisordersSleep Initiation and Maintenance DisordersActigraphyAdultAnalgesics, OpioidFemaleHumansMaleSleepAnalgesics, Opioidchronic paindailyinsomniaopioidsleep

Identifiers

PMID33226334
PMCPMC8020701
OpenAlexW3107491122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.